Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUSP3 | P51452 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | APAF1 | O14727 | 1/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9175310 | 0.83 | DUSP3 (0.52) | DUSP3KDM4EALDH1A1TDP1MEN1 | |
| SCHEMBL12957817 | 0.76 | MAOA (0.32) | MAOB | |
| SCHEMBL5590100 | 0.75 | CDC25A (0.32) | — | |
| SCHEMBL10609498 | 0.74 | DUSP3 (0.58) | DUSP3KDM4EALDH1A1TDP1MEN1 | |
| SCHEMBL22644817 | 0.74 | KDM4E (0.35) | KDM4EALDH1A1TDP1MEN1MAPT | |
| SCHEMBL13519618 | 0.70 | — | — | |
| SCHEMBL16309126 | 0.69 | DUSP3 (0.68) | DUSP3KDM4EALDH1A1TDP1MEN1 | |
| SCHEMBL27098390 | 0.68 | DUSP3 (0.77) | DUSP3KDM4EALDH1A1TDP1MEN1 | |
| SCHEMBL3413343 | 0.67 | CDC25A (0.37) | — | |
| SCHEMBL22874151 | 0.67 | CDC25B (0.54) | KDM4EALDH1A1TDP1MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090087420-A1 | STABLE SOLUTION OF REDUCED COENZYME Q | KANEKA CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090087420-A1 | STABLE SOLUTION OF REDUCED COENZYME Q | COQ8A, COQ8B, LRAT | DUSP3 3907/4885KDM4E 1434/4885ALDH1A1 3882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.